Quarterly report · Q1
2590.TEDINET S100QVFN
Period2023-01-21 → 2023-04-20
Filed2023-06-02
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥47.1bn | 2023-01-21 → 2023-04-20 | Cons. | Net sales |
| Revenue | ¥160.1bn | 2022-01-21 → 2023-01-20 | Cons. | Net sales (5-year summary) |
| Revenue | ¥34.9bn | 2022-01-21 → 2022-04-20 | Cons. | Net sales |
| Operating income | −¥539m | 2023-01-21 → 2023-04-20 | Cons. | Operating income |
| Operating income | −¥986m | 2022-01-21 → 2022-04-20 | Cons. | Operating income |
| Ordinary income | −¥442m | 2023-01-21 → 2023-04-20 | Cons. | Ordinary income |
| Ordinary income | ¥591m | 2022-01-21 → 2023-01-20 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2022-01-21 → 2022-04-20 | Cons. | Ordinary income |
| Profit before tax | −¥87m | 2023-01-21 → 2023-04-20 | Cons. | Income before income taxes |
| Profit before tax | −¥1.2bn | 2022-01-21 → 2022-04-20 | Cons. | Income before income taxes |
| Net income (owners) | −¥296m | 2023-01-21 → 2023-04-20 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥507m | 2022-01-21 → 2023-01-20 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.6bn | 2022-01-21 → 2022-04-20 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥299m | 2023-01-21 → 2023-04-20 | Cons. | Profit loss |
| Net income | −¥1.6bn | 2022-01-21 → 2022-04-20 | Cons. | Profit loss |
| Total assets | ¥179.1bn | at 2023-04-20 | Cons. | Assets |
| Total assets | ¥164.2bn | at 2023-01-20 | Cons. | Assets |
| Total assets | ¥165.3bn | at 2022-04-20 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥90.6bn | at 2023-04-20 | Cons. | Liabilities |
| Total liabilities | ¥80.1bn | at 2023-01-20 | Cons. | Liabilities |
| Net assets / equity | ¥88.5bn | at 2023-04-20 | Cons. | Net assets |
| Net assets / equity | ¥84.1bn | at 2023-01-20 | Cons. | Net assets |
| Net assets / equity | ¥83.0bn | at 2022-04-20 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥27.2bn | at 2023-04-20 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.2bn | at 2023-01-20 | Cons. | Cash and deposits |
| EPS (basic) | ¥-18.9 | 2023-01-21 → 2023-04-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-32.4 | 2022-01-21 → 2023-01-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-99.09 | 2022-01-21 → 2022-04-20 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 48.4% | at 2023-04-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.9% | at 2023-01-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.9% | at 2022-04-20 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-01-21 → 2023-04-20 | −¥77m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-21 → 2023-04-20 | −¥77m |
| Reconciling Itemsreconciling | segment profit | 2023-01-21 → 2023-04-20 | −¥151m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥34.7bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥34.7bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥12m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥238m |
| jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥133m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥4.1bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥4.1bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥1m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | ¥34m |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥5.3bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥5.3bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥84m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥3.0bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥3.0bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥63m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | ¥34m |
| —segment total | revenue | 2023-01-21 → 2023-04-20 | ¥47.2bn |
| —segment total | revenue external | 2023-01-21 → 2023-04-20 | ¥47.1bn |
| —segment total | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥77m |
| —segment total | segment profit | 2023-01-21 → 2023-04-20 | −¥387m |
| Reconciling Itemsreconciling | revenue | 2022-01-21 → 2022-04-20 | −¥134m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-21 → 2022-04-20 | −¥134m |
| Reconciling Itemsreconciling | segment profit | 2022-01-21 → 2022-04-20 | −¥270m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥24.8bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥24.8bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥12m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥325m |
| jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥96m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥4.3bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥4.3bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥1m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | ¥234m |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥3.1bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥3.1bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥499m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥2.9bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥2.7bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥120m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥28m |
| —segment total | revenue | 2022-01-21 → 2022-04-20 | ¥35.0bn |
| —segment total | revenue external | 2022-01-21 → 2022-04-20 | ¥34.9bn |
| —segment total | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥134m |
| —segment total | segment profit | 2022-01-21 → 2022-04-20 | −¥715m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 393
| Item | Context | Value | Unit |
|---|---|---|---|
| Remeasurements of defined benefit plans | CurrentQuarterInstant | -216000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | -1375000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 1062000000 | JPY |
| Non controlling interests | Prior1YearInstant | 476000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 1733000000 | JPY |
| Net assets | Prior1YearInstant | 84067000000 | JPY |
| Net assets | CurrentQuarterInstant | 88498000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 164204000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 179107000000 | JPY |
| Net sales | Prior1YTDDuration | 34912000000 | JPY |
| Net sales | CurrentYTDDuration | 47102000000 | JPY |
| Cost of sales | Prior1YTDDuration | 18801000000 | JPY |
| Cost of sales | CurrentYTDDuration | 25468000000 | JPY |
| Gross profit | Prior1YTDDuration | 16110000000 | JPY |
| Gross profit | CurrentYTDDuration | 21633000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 17096000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 22172000000 | JPY |
| Operating income | Prior1YTDDuration | -986000000 | JPY |
| Operating income | CurrentYTDDuration | -539000000 | JPY |
| Interest income noi | Prior1YTDDuration | 20000000 | JPY |
| Interest income noi | CurrentYTDDuration | 21000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 3000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 6000000 | JPY |
| Gain on valuation of investment securities noi | Prior1YTDDuration | 68000000 | JPY |
| Gain on valuation of investment securities noi | CurrentYTDDuration | 5000000 | JPY |
| Other noi | Prior1YTDDuration | 127000000 | JPY |
| Other noi | CurrentYTDDuration | 244000000 | JPY |
| Non operating income | Prior1YTDDuration | 219000000 | JPY |
| Non operating income | CurrentYTDDuration | 277000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 47000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 75000000 | JPY |
| Equity in losses of affiliates noe | Prior1YTDDuration | 17000000 | JPY |
| Equity in losses of affiliates noe | CurrentYTDDuration | 5000000 | JPY |
| Loss on retirement of noncurrent assets noe | Prior1YTDDuration | 33000000 | JPY |
| Loss on retirement of noncurrent assets noe | CurrentYTDDuration | 75000000 | JPY |
| Loss on the net monetary position noe | Prior1YTDDuration | 252000000 | JPY |
| Loss on the net monetary position noe | CurrentYTDDuration | 0 | JPY |
| Other noe | Prior1YTDDuration | 13000000 | JPY |
| Other noe | CurrentYTDDuration | 23000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 364000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 180000000 | JPY |
| Ordinary income | Prior1YTDDuration | -1130000000 | JPY |
| Ordinary income | CurrentYTDDuration | -442000000 | JPY |
| Insurance proceeds income ei | Prior1YTDDuration | － | JPY |
| Insurance proceeds income ei | CurrentYTDDuration | 421000000 | JPY |
| Extraordinary income | Prior1YTDDuration | － | JPY |
| Extraordinary income | CurrentYTDDuration | 421000000 | JPY |
| Loss on disaster el | Prior1YTDDuration | 59000000 | JPY |
| Loss on disaster el | CurrentYTDDuration | － | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |